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Clearance of immune complexes by the mononuclear phagocyte system is
important for maintaining normal host defenses againstbacterial and viral assault
(1), but also contributes to the pathogenesis of a variety of immune-mediated
diseases. For example, removal from the circulation of IgG-coated erythrocytes
and platelets by the MPS is the sine qua non of immune-mediated cytopenias (2,
3). On the other hand, abnormally decreased removal by the MPS of smaller,
soluble immune complexes may play a role in the pathogenesis of immune
complex-mediated tissue damage found in such autoimmune diseases as SLE (4).
Although the physicochemical nature and the size of immune complexes can
influence rates of clearance and sites of deposition (reviewed in 5), interactions
between immune complexes and the MPS in vivo are poorly understood . The
inability to directly measure binding or internalization of immune complexes by
cells in the liver and spleen has made the analysis of the molecular basis of
immune complex clearance very difficult. Receptors for the Fc portion of IgG
(FcyR) and for complement (CR) undoubtedly play a role in the removal of
immune complexes, but the relative importance ofthese receptors is not known.
There are three types of FcyRs on human leukocytes. A 72 kD receptor with
high affinity for monomeric IgG is found on monocytes (6) and some resident
macrophages (7). Two receptors exist with low affinity for monomeric IgG, one
with broad electrophoretic mobility (51-73 kD) on neutrophils (8), natural killer
cells (9), and macrophages (8); the other recently described (40 kD) on platelets
(10), monocytes (10), and several tumor cell lines (11). All three bind immuno-
globulin that is aggregated or complexed to antigen. The 51-73 kD receptor is
recognized by mAb 3G8, which blocks ligand binding and has been very useful
in the partial biochemical characterization of this receptor (8).
In vitro analysis of the role played by FcyRs in individuals with abnormally
prolonged clearance of opsonized red cells (model particulate immune com-
plexes) generally has been limited tostudies ofhigh-affinity FcyRson monocytes.
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These studies, however, have shown no decrease in number or ligand-binding
properties of high-affinity FcyRs (12).
The distribution ofthe Fc7R recognized by mAb 3G8 on resident macrophages
suggests that this receptor may be more relevant than are high-affinity FcyRs
with respect to the clearance of immune complexes. Support for this hypothesis
has come from studies performed by Kurlander et al. (13) with mAb 2AG2,
which recognizes and blocks ligand binding to a murine low-affinity FcYR (14) .
Kurlander showed that administration of 2 .4G2 (both as intact IgG and as Fab
fragments) dramatically prolonged clearance of several types of soluble immune
complexes, but had no effect on clearance of monomeric IgG. These observa-
tions, however, may not be applicable to humans. Whereas both rodents and
primates express low-affinity FcyRs and CRs on their resident macrophages, only
primates possess CRs for C3b and C4b (CR1) on their erythrocytes (15, 16).
These erythrocyte CRs may also be important in clearance of immune complexes.
In this report, we describe results of experiments designed to investigate the
role played by 51-73 kD FcyRs in clearance of immune complexes by primates.
We first examined localization in primate liver of cells reactive with mAb 3G8 .
We then established a model in primates in which we could accurately measure
clearance of both particulate and soluble model immune complexes. Finally, we
have used mAb 3G8 to examine the role in vivo of this receptor in immune
clearance.
Materials and Methods
Animals.
￿
Blood was obtained from healthy adult chimpanzees, rhesus monkeys, ba-
boons, and gibbons maintained at the New York University Laboratory of Experimental
Medicine and Surgery in Primates (LEMSIP), Tuxedo Park, NY; and from owl monkeys,
African green monkeys, cebus monkeys, and stump-tailed macaques from the Atheroscle-
rosis Research Center, Winston-Salem, NC. Chimpanzees used to study clearance of IgG-
opsonized erythrocytes (RBC) were positive for blood group A'B`D`. All experimental
procedures were performed at LEMSIP with animals that were lightly anesthetized with
ketamine .
Preparation of Antibodies.
￿
3G8, a murine IgGI mAb (8), and MOPC 21, a murine
IgGI myeloma protein were isolated from ascites by precipitation with 45% ammonium
sulfate followed by precipitation with caprylic acid (Sigma Chemical Co., St . Louis, MO)
(17). Fab fragments were prepared by digestion with papain-Sepharose (Sigma Chemical
Co.), and were purified by passage over protein A-Sepharose (Pharmacia Fine Chemicals,
Piscataway, NJ) at pH 8.3 and by molecular sieve chromatography over a column of TSK
3000 (LKB Instruments, Inc., Rockville, MD). Proteins were >95% pure, and Fab
fragments contained no detectable heavy chains, as judged by silver staining after SDS-
PAGE (BioRad Laboratories, Richmond, CA). Preparations used for infusions were sterile
and contained <0.25 ng of endotoxin per milligram of total protein, as determined by
limulus amoebocyte assay (Associates of Cape Cod, Woods Hole, MA). Before use,
antibody preparations were dialyzed against 0 .15 M NaCl (USP), and aggregates were
removed by ultrafiltration. mAb YZ-I Fab (18) was the generous gift of Dr. Richard Jack,
Harvard Medical School, Boston, MA.
Preparation of Opsonized RBCs.
￿
Chimpanzee RBCs were sensitized with chimpanzee
anti-A'B'D` antiserum (generously supplied by Dr. W . W. Socha, LEMSIP). The number
of molecules of IgG-RBC was determined using a solid-phase RIA. Briefly, 10' sensitized
RBCs were lysed in PBS containing 1 .0% NP-40 (vol/vol), 1 .0% aprotinin (wt/vol), and
0.02% (wt/vol) NaN3 . After removal of stroma by centrifugation (10,000 rpm, 15 min),
serial dilutions of lysate were plated in 96-well microtiter plates (Dynatech Laboratories,
Alexandria, VA) previously coated with affinity-purified goat Fab anti-human Ig (a4'76
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generous ~ift of Dr. N . Chiorazzi, The Rockefeller University). After incubation and
washing, ' 'I-labeled anti-human Ig (106 cpm/ml) was added. The approximate number
of molecules of IgG-RBC was calculated from a standard curve constructed with purified
human IgG.
A qualitative assessment of fixation of complement to the RBCs with the anti-A'B'D`
antiserum was determined by incubating sensitized RBCs with whole fresh chimpanzee
serum at 37°C for 60 min. RBC-bound C3 was detected by hemagglutination with an
anti-human C3 antiserum (Cappel Laboratories, Malvern, PA).
Immediately preceeding clearance studies, autologous RBCs were washed with 0.150
M NaCl and then adjusted to 108 cells/ml . Antiserum titered to yield either 2,000 or
20,000 IgG molecules per RBC (see Results), and "Cr (New England Nuclear, Boston,
MA) was added and incubated for 30 min at 37'C. The cells were washed and resuspended
in 10 ml of 0 .150 M NaCl. The cells were held on ice and used within 15 min .
Protocolfor Measuring Clearance of Opsonized RBCs.
￿
Clearance studies of autologous,
opsonized RBC were performed using minor modifications of methodology described by
Frank, et al . (19). 108 "Cr-labeled, opsonized RBCs in 10 ml 0.15 M NaCl were injected
into an antecubital vein as rapidly as possible (<5 s). Blood samples (5.0 ml) were drawn
from the opposite antecubital vein 3, 5, 15, 30, 60, 90, and 120 min after injection to
determine the baseline rate of clearance of sensitized RBCs. Antibody or saline was then
infused over 30 min, and clearance of freshly sensitized RBCs was measured using an
identical protocol .
Preparation ofSoluble Immune Complexes.
￿
'2'I-labeled double-stranded (ds)' DNA-anti-
DNA soluble immune complexes (generously provided by Dr. Ronald Taylor, Department
of Biochemistry, University of Virginia School of Medicine) were prepared as previously
described (20, 21). Briefly, ' 2'I-dsDNA of -x1,200-1,400 by was incubated with anti-
DNA antibodies purified from SLE plasma (Ma, previously described by Taylor and
Morgan [22]) in ^-40-fold antibody excess for 45 min at 37°C . The sedimentation
coefficient, determined by sucrose density velocity sedimentation of the immune com-
plexes, was <I00 S.
Experimental Protocol for Clearance of Soluble Immune Complexes.
￿
'251-dsDNA-anti-
DNA or '2'I-dsDNA alone was injected into an antecubital vein as rapidly as possible (<5
s). Blood samples (5.0 ml) were then drawn from the opposite antecubital vein every 30 s
for the first 3 min, then at 5, 7 .5, 10, 20, and 30 min . As above, each animal received
intravenous antibody or saline over 30 min, then a second clearance study was performed
using an identical protocol .
Each 5.0 ml sample of blood was immediately heparinized, placed on ice, and then
centrifuged (2,000 rpm, 5 min). Cell pellets were resuspended in cold PBS, and centrifuged
again (2,000 rpm, 5 min) within 10 min. Cell pellets, which contained RBC- and leukocyte-
bound immune complexes, were saved and counted. Plasma and supernatants from washed
cells were processed within 15 min to determine the amount of labeled dsDNA that was
antibody-bound, free, or degraded. Aliquots (1 .0 ml) were mixed with one-half vol of
15% TCA and allowed to precipitate at room temperature. Another 1 .0 ml aliquot and
saturated ammonium sulfate (for a final concentration of 40%, vol/vol) were allowed to
precipitate on ice. These samples were centrifuged at 5,000 rpm for 20 min to recover
precipitates and supernatants, which were counted separately. The third aliquot was saved
unaltered.
Determination of Cell Numbers.
￿
Absolute numbers of circulating leukocytes were cal-
culated using complete blood counts and differential counts determined by microscopic
examination of stained blood smears.
Murine Immunoglobulin in Serum and Bound to Cells.
￿
Levels of murine immunoglobulin
in serum were determined using a solid-phase sandwich RIA as previously described (23) .
Neutrophils and mononuclear cells were isolated from chimpanzee and human blood
using a two-step Ficoll-Hypaque density centrifugation technique (24). Neutrophils and
mononuclear cells were incubated with appropriate mAbs (see below), followed by fluo-
rescein-conjugated goat anti-mouse Ig, or fluorescein-conjugated anti-rabbit Ig (Cappel
' Abbreviations used in this paper:
￿
ds, double-stranded; IC, immune complex.CLARKSON ET AL.
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FIGURE 1 .
￿
Comparison of indirect immunofluorescence of human (A) and chimpanzee (B)
neutrophils. In this flow cytometric analysis, cell number is represented on the ordinate and
fluorescent intensity on a log scale on the abscissa. The dotted lines represent background
staining with anti-mouse Ig-FITC alone, and the solid lines show staining with mAb 3G8
IgG.
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Laboratories). Cells were analyzed on a FACS IV flow cytometer (Becton-Dickinson
Immunocytometry Systems, Mountain View, CA), which was calibrated before each run
with 7 .5 jum fluorescent beads (Flow Cytometry Standards Corp., Research Triangle Park,
NC). The mAbs used included 3G8, Leu-7 (a generous gift of Dr. Robert Evans, Sloan-
Kettering Memorial Cancer Center, New York) (25), and phycoerythrin-conjugated Leu-
M3 (Becton-Dickinson Immunocytometry Systems) (26) .
Immunohistological Studies.
￿
Sections of chimpanzee and human tissue were fixed either
in acetone or in a mixture of 4% (vol/vol) paraformaldehyde, 0.075 M lysine, and 0.01
M periodate, as described previously (27). Thin sections were applied to multiwell slides
and incubated with mAbs. Bound antibody was detected using diaminobenzidine-H202
after incubation with peroxidase-conjugated goat F(ab')2 anti-mouse Ig or biotin-conju-
gated horse anti-mouse Ig and avidin-peroxidase complexes (Vector Laboratories, Inc.,
Burlingame, CA).
Cytotoxicity. Chimpanzee and human neutrophils (2 X 105 cells/ml) were incubated
with mAb 3G8 IgG (10 pg/ml) in 96-well microtiter dishes, and washed. Baby rabbit
complement (Pel-Freeze, Rogers, AR) was then added for 30 min. The cells were washed
again, and cell death was determined by counting cell number, and using trypan blue
exclusion .
Blockade ofRosette Formation.
￿
Chimpanzee and human neutrophils were plated on 60-
well microtiter plates previously coated with 100 jAg/ml poly-L-lysine (Sigma Chemical
Co.). Then the cells were incubated with either mAb 3G8 IgG or saline for 30 min at
4.5°C. After washing, 10 Al of a 2% suspension of IgG-sensitized SRBC was added and
incubated at room temperature for 30 min . Nonrosetted RBCs were removed, and
rosetted cells (at least three RBCs attached to cell surface) were counted.
Statistical Analysis.
￿
Paired and nonpaired t tests were used as noted. For measurement
of clearance rates, the logarithm of the percentage of radioactivity remaining in the blood
was plotted as a function of time, and the clearance half-time was calculated.
Results
mAb 3G8 Binds to Chimpanzee Neutrophil FcyRs. We surveyed neutrophils
from eight great ape and monkey species for the presence of neutrophil FcyRs
that resembled those on human neutrophils with respect to reactivity with mAb
3G8, as well as to function . Only neutrophils from the chimpanzee (Pan troglo-
dytes) expressed the antigen recognized by mAb 3G8. Fig. I represents a flow-478
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cytometric analysis demonstrating that >95% neutrophils from both human and
chimpanzees reacted with niAb 3G8 and were of similar fluorescence intensity .
FcyRs on chimpanzee neutrophils also resembled human 51-73 kD FcyRs
with respect to function in vitro . In parallel experiments, 97 ± 1.8% chimpanzee
and 98 ± 2.3% human neutrophils formed rosettes with IgG-coated RBCs .
Furthermore, mAb 3G8 inhibited rosetting to a similar degree in both species:
82 ±6% in the chimpanzee and 87 ±4.5% in the human . In neither species was
mAb 3G8 cytotoxic to neutrophils in the presence of complement .
Tissue Distribution ofFcyR in Man and Chimpanzee .
￿
We examined sections of
human spleen, liver, and lymph nodes for cells recognized by mAb 3G8. Sections
of spleen (not shown) showed striking segregation of reactivity to red pulp, the
region that contains the majority of resident macrophages (28) . White pulp,
populated predominantly by lymphocytes, was negative . Sections oflymph node
were also negative, suggesting that resident macrophages of different organs
may differ in their expression of the 3G8 epitope .
Liver sections of both humans (not shown) and chimpanzees (Fig . 2) stained in
a pattern consistent with the localization of Kupffer cells (29) . Therefore, we
concluded that the 3G8 epitope was present in tissue sites important in clearance
ofimmune complexes. Furthermore, at least in liver, staining ofchimpanzee and
human tissue appeared comparable .
Effects ofmAb 3G8 on Clearance of Opsonized RBCs .
￿
In our initial experiments,
we observed that clearance of opsonized RBCs from the circulation of the
chimpanzee was dependent on the number of molecules of IgG per RBC.
Whereas RBCs sensitized with 2,000 molecules of IgG per RBC were cleared
with a t., of >70 h (Fig . 3), RBCs sensitized with 20,000 molecules of IgG per
RBC were cleared with a baseline t., of 50-100 min. Consequently, to examine
effects of mAb 3G8 on clearance, all subsequent experiments were performed
usingRBCs coated with 20,000 molecules of IgG perRBC.
Clearance of IgG-opsonized RBCs before and after animals received infusions
of saline, mAb 3G8, and MOPC 21 is shown in Fig . 4. Clearance curves before
and after infusions of saline (Fig . 4A), and 1 mg/kg ofMOPC 21 (Fig . 4B) were
virtually superimposable . Thus, neither prolonged anesthesia nor the prior
administration of opsonized RBCs per se had an appreciable effect on the
subsequent clearance of opsonizedRBCs . Results obtained after infusing MOPC
21, an IgGI murine myeloma protein, indicated that a nonspecific murine
immunoglobulin also had no effect on clearance .
In contrast, infusion of 1 mg/kg of mAb 3G8 IgG (Fig . 4C) increased the t .1,
from an average of 90 min to 4,095 min, a 48-fold increase (p< 0.005). There
was a large difference in the magnitude of effect in the two animals studied . 3G8
Fab fragments (1 .0 mg/kg) (Fig . 4D) also increased the t .,, significantly, from an
average of 130 min to 1,772 min (p < 0.001) . Although the magnitude of
increase (13.6-fold) was not as great as that seen with intact mAb 3G8 IgG, we
concluded that the effect of 3G8 was at least in part due to Fab-mediated
blockade of the 51-73 kD FcyR .
Fig . 5 summarizes the changes in t~l, in all experiments using sensitized RBCs
beforeandafter the indicated infusions, including the additional control infusion
ofYZ-1 Fab, an anti-CR 1 mAb. The small change in t.1, seen with this antibodyCLARKSON ET AL .
FIGURE 2. Immunoperoxidase staining of chimpanzee liver . Chimpanzee liver sections
stained with control mAb (A), mAb 3G8 Fab (B), and 9.3 (anti-class II) (C) . Staining in a
sinusoidal pattern typical for the distribution of Kupffer cells is seen with both mAb 3G8 and
9.3 .
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FIGURE 3.
￿
Effect on clearance of opsonized RBCs of two doses of opsonizing antibody, and
the effect on clearance of mAb 3G8 IgG infusion. ty of clearance in chimpanzee 456 was 50
min using the larger dose of opsonizing anti-RBC antibody (O--Q). After infusion, t-,,
increased to 1,410 min (0----- ). Using the smaller dose of opsonizing antibody, ti in
chimpanzee 454 was>70 hbefore mAb 3G8 infusion
￿
and notsignificantlydifferent
from the postinfusion t.,, (0-----0).
(also of the IgG1 subclass) suggests that the change seen with mAb 3G8 infusions
was not due simply to the nonspecific effect of interactions between phagocytes
andantiphagocyte antibodies, or even to interactions between receptors involved
in some types of phagocytosis and antireceptor antibodies in general. Fig. 5 also
demonstrates that infusion of as little as 0.125 mg/kg of mAb 3G8 significantly
increased the t",2. Effects of infusing 0.25 and 0.5 mg/kg were indistinguishable
from those observed after infusion of 1.0 mg/kg.
Murine Immunoglobulin in Serum and on Cells.
￿
36 min after infusion, the level
of circulating mAb 3G8 IgG and 3G8 Fab in serum was >2 .0 ug/ml (Fig. 6), a
concentration presumably sufficient to react with all of the 51-73 kD FcyRs on
circulating leukocytes and tissue macrophages (8). Both mAb 3G8 Fab fragments
and 3G8 IgG disappeared rapidly from the circulation, such that no mouse Ig
was detectable after 8 d. The myeloma protein MOPC 21 disappeared at a
slower rate, suggesting that the rapid rate of disappearance of mAb 3G8 was not
due to nonspecific catabolism of foreign immunoglobulin, but rather to removal
by circulating and tissue cells that bear FcyRs recognized by mAb 3G8.
Because 51-73 kD FcyRs are expressed on all mature neutrophils, mAb 3G8FIGURE 4.
￿
Effect of saline and antibody infusions on clearance of IgG-coated RBCs . Each
figure represents clearance curves before (0---*)and after (0-----0) the indicated infusions.
The curves represent the average of the indicated numbersof experimental animals .
FIGURE 5.
￿
Effect on t, (ordinate) ofclearance before and after the indicated infusions . Points
on left side of each panel represent t, before infusions, and points on right, t, after infusions .
Doses ofmAb3G8 IgG are depicted in the fourth panelfrom the left : 1 mg/kg (0), 0.5 mg/kg
(O), 0.25 mg/kg (O), and 0.125 mg/kg (p) .
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FIGURE 6 .
￿
Serum levels of 3G8 IgG, 3G8 Fab, and MOPC 21 . Infusions of I mg/kg were
performed at time 0, and serial serum antibody levels were measured by solid-phase RIA . All
three antibodies attained peak levels of >2 kig/ml immediately after infusion .
FIGURE 7 . Flow-cytometric analysis of chimpanzee neutrophils after indicated infusions .
Background staining of an irrelevant anti-rabbit Ig-FITC (dashed lines) is compared to the
staining of an anti-mouse Ig-FITC (solid lines), which recognizes the infused antibodies .
should bind to these cells in vivo . We examined circulating neutrophils and
mononuclear cells obtained after the infusions for bound murine IgG by immu-
nofluorescent staining . Fig . 7 shows that, while there was no appreciable binding
of saline (Fig . 7A) or MOPC 21 (Fig . 7B) to neutrophils, all neutrophils bound
the infused mAb 3G8 IgG (Fig . 7C). 3G8 Fab showed comparable reactivity
with neutrophils (Fig . 7D) . By 8 d after infusion of mAb 3G8, there was no
detectable mouse Ig on neutrophils (not shown) .
There was no detectable mAb 3G8 reactivity on circulating monocytes by two-
color flow-cytometric analysis using a phycoerythrin-conjugated antimonocyte
mAb Leu-M3 and 3G8 (not shown) . Lymphocytes were not examined for
reactivity with mAb 3G8.
Changes in Circulating Leukocyte Populations .
￿
We monitored serial complete
blood counts to study the effect of opsonization in vivo on circulating leukocytesCLARKSON ET AL.
￿
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FIGURE 8.
￿
Effect of indicated antibody infusions on circulating leukocyte populations. Ab-
solute neutrophil counts arerepresented in A, absolute monocyte counts arerepresented in B,
and absolute lymphocyte counts are in C.
(Fig. 8). Absolute neutrophil counts (Fig. 8A) decreased precipitously immedi-
ately after infusion of mAb 3G8 IgG, and remained depressed until day 5, in
close parallel to serum 3G8 levels . Although neutrophils displayed bright im-
munofluorescence with mAb 3G8 Fab, there was no decrease in absolute neutro-
phil counts after infusion of mAb 3G8 Fab. In fact, absolute neutrophil counts
displayed only the small rise also seen with MOPC 21 and saline infusions, which
is probably due to the stress of general anesthesia.
An immediate decrease in circulating monocytes was also seen only with mAb
3G8 IgG infusions (Fig. 8B), despite the absence of immunofluorescent staining
of monocytes by mAb 3G8. The number of circulating monocytes returned to
normal by 24 h, but by day 3 was increased as compared to saline controls. The
number of circulating lymphocytes showed no significant differences following
any type of infusion (Fig. 8C) .
Duration ofEffect.
￿
We repeated clearance studies at 10 and 42 d after infusion
of mAb 3G8 IgG in two animals. By day 10, when the absolute neutrophil count
was normal and there was no demonstrable mAb 3G8 IgG in serum or on
neutrophil cell surfaces, clearance of opsonized RBC remained quite prolonged
(Fig. 9). By day 42, however, clearance returned to values obtained before
infusion of mAb 3G8. The chimpanzees have remained in good health 2-16 mo
after mAb 3G8 infusion, without clinical evidence ofimmune complex-mediated
diseases such as arthritis, serum sickness, or glomerulonephritis.
Clearance ofSoluble Immune Complexes.
￿
We next examined clearance of solu-
ble "'I-dsDNA-anti-DNA immune complexes. Soluble dsDNA-anti-DNA im-
mune complexes behaved quite differently from opsonized RBCs. Both IgG-
anti-dsDNA (IgG immune complex; IgG-IC) and IgM-anti-dsDNA (IgM-IC)
quickly bound to RBCs after intravenous injection: 41-57% of IgG-IC and 57-
78% of IgM-IC were RBC bound; the remaining counts were free in serum. In
Exp. 1, both types of immune complexes were cleared rapidly from the circula-484
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FIGURE 9.
￿
Duration of effect of InAb 3G8 IgG on the prolongation of clearance of IgG-
coated RBCs.
tion, the IgG-IC with a t.,, of total counts of 155 s, and IgM-IC with a t.1, of 75 s.
After infusion of 1 mg/kg of mAb 3G8 Fab, the clearance of both types of
particles was slowed a small, and equal amount (not shown). This effect, there-
fore, was not specific for IgG-IC.
In Exp. 2, again 42-57% of IgG-IC were quickly bound to RBCs afterinjection.
Neither mAb 3G8 Fab nor a control saline infusion significantlyslowed clearance
of either RBC-bound or free immune complexes. Interestingly, clearance rates
of free immune complexes were slower than that of RBC-bound fractions, and
approximated the rate of clearance of I25I-dsDNA that was not complexed with
anti-DNA antibodies. It appeared that mAb 3G8 Fab infusions had little effect
on clearance of these soluble ' 25I-dsDNA-anti-DNA complexes.
This paper presents both immunohistological and in vivo functional data which
suggest that 51-73 kD FcyRs are important in clearance of immune complexes.
This FcyR is present in high concentration in human liver and spleen, and in
chimpanzee liver, tissues important for clearance of immune complexes. We
showed that intravenous infusion of an mAb that blocks ligand binding by 51-
73 kD FcyRs dramatically prolongs clearance of IgG-sensitized RBCs in primates.
This effect was seen with doses of mAb as low as 0.125 mg/kg, and persisted for
at least 10d.
Studies by Atkinson and Frank (30), and Schreiber and Frank (31) showed
that rates of clearance and sites of deposition of opsonized RBCs depend upon
the nature of the opsonin. RBCs sparsely coated with IgG are removed primarilyCLARKSON ET AL.
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by the spleen, and therate of clearance is relatively constant (31). RBCs opsonized
with IgM and C3bi are rapidly sequestered in the liver, and then are equally
rapidly released back into the circulation . A slow component ofclearance follows
their re-release (30) . Analyses of rates of clearance after complement depletion
(31) and in complement-deficient animal models (30) show that CRs probably
mediate the early sequestration of IgM- and C3bi-coated RBCs (30), and possibly,
the early phase of IgG-sensitized RBC clearance (31, 32). However, the relative
importance of FcR and CR in later phases of clearance is unknown.
The liver is the predominant site of clearance of antibody-protein immune
complexes in antibody excess (33). Work by Cornacoff, et al. (33) and Waxman,
et al. (34) suggested that primate RBCs bind very large antibody-protein immune
complexes via CRs for C3b and C4b (CR1) (33), and that the RBCs are stripped
of immune complexes in the liver and returned to the circulation . After comple-
ment depletion, rates of clearance from the circulation increase (34), which
suggests that tissue FcRs or other phagocytic mechanisms play a more important
role than CR in the actual removal of soluble immune complexes from the
circulation. Reduction and alkylation of internal disulfide bonds of IgG pro-
longed clearance of small soluble immune complexes in rhesus monkeys (35) .
However, the specific contribution of the FcyR has not been examined, as
reduction and alkylation of IgG interferes with both fixation of complement to
IgG (36) and binding of IgG to FcyRs (37).
In these experiments we took advantage of the specificity of an mAb against a
defined antigen, the 51-73 kD FcyR, and demonstrated dramatic blockade of
clearance of sensitized RBCs by small doses of 3G8. There are, however, at least
three possible mechanisms to explain effects of infusion of mAb 3G8 IgG on
clearance ofopsonized RBCs. The first is that 3G8 Fab mediates specific blockade
of 51-73 kD FcyRs. We believe that the dramatic effect of infusion of mAb 3G8
Fab on clearance of opsonized RBCs, without apparent removal of circulating
neutrophils or monocytes, strongly supports this hypothesis.
The second possibility is nonspecific blockade of all phagocytosis by the MPS
due to massive uptake of opsonized neutrophils. The more pronounced blockade
that resulted from infusions of intact mAb 3G8 IgG suggests that both the first
and second mechanisms contribute. However, decreased binding affinity of
monovalent Fab fragments compared to bivalent IgG may also account for some
of the difference in effect . The third possibility is that interaction with any
antimacrophage antibody nonspecifically paralyzes tissue macrophages. This is
not likely, because infusion of YZ-1 Fab, an anti-CR1 mAb, had very little effect
on clearance of sensitized RBCs. Additionally, in vitro work documents the
independent action of many antimacrophage antibodies directed against other
epitopes and FcyR function (38).
Infusions of mAb 3G8 Fab had a small and inconsistent effect on clearance of
soluble dsDNA-anti-DNA complexes. Given the large array of both FcyRs and
CR on phagocytes, it is possible that other receptors are more important than
51-73 kD FcyRs in clearance of this type of immune complex. In fact, data
obtained in both rhesus monkeys (35) and baboons (34) suggest that complexes
formed in large antibody excess (such as ours) are handled predominantly by the
complement system. Additionally, the relatively lower binding affinity of mon-486
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ovalent mAb 3G8 Fab compared to bivalent 3G8 IgG may not be sufficient for
soluble immune complex blockade. Therefore, we concluded that the effect of
niAb 3G8 was confined to blockade of IgG-sensitized RBCs in our system.
The prolonged effect seen with infusions of mAb 3G8 IgG, beyond the
duration that 3G8 was detected in serum or on cells, is of particular interest.
This phenomenon may be due simply to occupation of receptors by levels of
antibody below the sensitivity of our RIA and immunofluorescence assay, or
despite theabsence of in vitro cytotoxicity, to in vivo cytotoxicity to macrophages
by mAb 3G8. The return of receptor function after 10 d may be due to either
macrophage repopulation or to new synthesis of FcyRs. The time course of
effect of mAb 3G8 IgG agrees with the theoretical turnover time of resident
macrophage of 10-14 d determined in rodents by Crofton, et al. (39). Another
possibility is that mAb 3G8 IgG causes irreversible modulation of FcyRs from
cell surfaces of resident macrophages. However, modulation without resynthesis
of receptors within 24 h would be in contradistinction to the type of modulation
of FcyRs reported (40) in murine macrophage cell lines, in which resynthesis of
FcRs occurred by 24 h.
Significant side effects of mAb 3G8 appeared to be limited to transient
neutropenia. There was no clinical evidence of immune complex-mediated
disease, such as glomerulonephritis or arthritis. The profound effect of the mAb
on the clearance of sensitized RBCs, coupled with the relative absence of side
effects may lead to the better understanding of the pathogenesis, and possibly to
new treatment modalities of immune-mediated hemolytic anemia and thrombo-
cytopenic purpura.
Human low-affinity, 51-73 kD IgG FcR, found on macrophages, neutrophils,
and natural killer cells, may play a significant role in clearance of sensitized
RBCs. We showed that FcyRs are present in human liver and spleen, and in
chimpanzee liver by immunoperoxidase staining using a murine IgG1 anti-
human Fc7R mAb, 3G8. We then established a chimpanzee model in which to
study 51-73 kD FcyRs. Inhibition by mAb 3G8 of immune complex binding to
chimpanzee and human neutrophils in vitro, and the distribution of mAb 3G8
reactivity on circulating human and chimpanzee leukocytes was comparable.
We studied the role of FcyRs in clearance of immune complexes by infusing
mAb 3G8 in chimpanzees. Intravenous infusion of mAb 3G8 IgG profoundly
prolonged in vivo clearance of model immune complexes (IgG-opsonized, au-
tologous, "Cr-labeled RBCs) from an initial clearance half-time of 90 min to
4,095 min immediately after infusion . Infusion of mAb 3G8 Fab had a similar
effect, while saline, an anti-CR1 mAb, and murine IgGI myeloma protein
infusions had little effect. Transient neutropenia occurred at 24 h only with
intact tnAb 3G8 IgG infusions, and resolved by day 5. The duration of effect
was at least 10 d, outlasting detection of 3G8 in serum and on neutrophils.
Infusions of 3G8 Fab appeared to have little effect on clearance of double-
stranded (ds) DNA-anti-dsDNA soluble immune complexes. mAb blockade of
FcyRs prolongs in vivo clearance of IgG-sensitized RBCs, suggesting that FcyRs
may play an important role in clearance of this type of immune complex.
We thank Dr. W. W. Socha for supplying the anti-chimpanzee RBC antiserum, Dr.Thomas B. Clarkson for providing blood from several primate species, and Brian Ruede,
Lewis Miriam, Nancy Tappe, Julie Fitgerald, and John Wiebolt, and the staff of LEMSIP
for excellent technical assistance.
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